Paper Details

  1. Home
  2. Paper Details

The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.

Author: Gafter-GviliAnat, MuchtarEli, RaananiPia, RamRon, ShpilbergOfer, VidalLiat

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Acute promyelocytic leukemia (APL) is a type of leukemia with a high cure rate. While everyone agrees on the need for initial treatment and consolidation (further treatment after remission), the role of maintenance therapy (long-term treatment after consolidation) is debated.
Paper Details　
Original Abstract of the Article :
Acute promyelocytic leukemia (APL) is the most curable type of leukemia. A consensus exists regarding the need for administration of both induction and consolidation treatments, albeit using different approaches. However, there is conflicting evidence for the role of maintenance treatment in APL pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD009594.pub2

データ提供：米国国立医学図書館（NLM）

The Role of Maintenance Therapy in Acute Promyelocytic Leukemia

This review explores the role of maintenance therapy in acute promyelocytic leukemia (APL), a challenging type of leukemia. It's like navigating a treacherous desert, where we need to carefully consider each step to ensure a successful journey. The review discusses the current consensus regarding the use of induction and consolidation treatments for APL, but it highlights the conflicting evidence for the role of maintenance therapy. This review explores the need for a more comprehensive understanding of the role of maintenance therapy in APL patients to ensure optimal outcomes.

While APL is considered the most curable type of leukemia, the debate around maintenance therapy underscores the need for ongoing research in this area. It's like searching for a reliable water source in a desert – we need to constantly evaluate our strategies to ensure we're using the best tools available. This review underscores the need for further research and evidence-based guidelines for the use of maintenance therapy in APL patients.

Understanding Leukemia Treatment

This review emphasizes the importance of ongoing research and evidence-based decision-making in the treatment of leukemia. It's like having a skilled desert guide – we need to rely on the latest knowledge and tools to navigate this challenging medical landscape.

Improving Leukemia Outcomes

This research highlights the need for a more comprehensive understanding of the role of maintenance therapy in APL patients. It's like searching for a hidden oasis in the desert – we need to explore new possibilities and refine our strategies to improve the outcomes for individuals facing this challenging disease.

Dr.Camel's Conclusion

This review delves into the complexities of acute promyelocytic leukemia (APL) treatment, highlighting the ongoing debate about the role of maintenance therapy. It's like navigating a vast desert, where we need to carefully consider each step to ensure a successful journey. By continuing to research and refine our treatment approaches, we can ultimately improve the outcomes for individuals battling this challenging disease.

Date :
  1. Date Completed 2013-07-12
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23543579

DOI: Digital Object Identifier

10.1002/14651858.CD009594.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.